Filter By:
Novel agents emerging for the treatment of lymphoma are offering some patients the opportunity of long-term disease control while avoiding aggressive and highly toxic chemotherapy therapies. For the time being, this means changing the goal of treatment from cure to control. Can patients live well wi...
by:patientpower | 23 views
Download from iTunes: https://itun... Lung cancer is being fought on three fronts at MD Anderson Cancer Center: prevention, early detection and treatment of advanced disease. John Heymach, M.D., Ph.D., professor in Thoracic/Head and Neck Medical Oncology at MD Anderso...
by:mdanderson | 16 views
Often, patients wonder, "What is small lymphocytic leukemia (SLL) and how does it differ from chronic lymphocytic leukemia (CLL)?" A leading CLL expert, Dr. John Pagel, explains the biology of SLL and the approach to treatment, including a drug recently approved for the disease. Get email alerts | http://www.p......
by:patientpower | 98 views
http://cance... The stigma of lung cancer can lead to shame, fear, and sub-optimal care. Dr. Joan Schiller wants us all to get past it, and she's leading the charge to make that happen. February 2014. GRACEcast 268 Lung
by:cancergrace | 60 views
Where are we now with treatment approaches for follicular and indolent lymphomas? What is in store for the near future? How are monoclonal antibodies changing therapy today? In this video, Dr. Wyndham Wilson, from the National Cancer Institute, joins Dr. John Gribben, from the Barts Cancer Center in London, at the 2014 International Workshop on Non...
by:patientpower | 24 views
How can you tell if you might have Follicular Lymphoma (FL), a common type of indolent non-Hodgkin lymphoma (NHL). Learn the signs and symptoms from Dr. Wyndham Wilson from the National Cancer Institute (NCI). Read the transcript | http://www.p...-...
by:patientpower | 133 views
Newly approved medications are beginning to offer patients with indolent lymphomas new options for continuous disease control, while avoiding some of the side effects of traditional chemotherapy treatments. The question for many patients is whether or not these drugs might extend their lives longer ...
by:patientpower | 29 views
Results of the MPACT Trial (weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone) in patients with metastatic pancreatic cancer will be reviewed, with emphasis on patient selection and neuropathy management. The webinar was delivered by Dr. Malcolm Moore, Program Head, Medical Oncolog...
by:oncologyeducation | 384 views
The objective of this webinar was to provide an overview of the available front-line therapeutic options for patients with metastatic pancreatic cancer and compare the relative effectiveness and potential side effect profiles of different chemotherapeuti​c regimens.
by:oncologyeducation | 1662 views
As chief of the lymphoma/myelom​a service at Roswell Park Cancer Institute in Buffalo, New York, Dr. Myron Czuczman, is feeling very positive about the latest developments in fighting lymphomas. In this thoughtful interview, recorded at the 2014 International Workshop on Non-Hodgkin Lymphoma (iwNHL),...
by:patientpower | 76 views

Top Tags

Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Different type of MD 
Other oncology Professional 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.

username:   password: remember me

Sign In

Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)